Incyte (INCY) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,228.66% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 91.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.73% |
| Dec 31, 2025 | 48.74% |
| Sep 30, 2025 | 298.45% |
| Jun 30, 2025 | 191.09% |
| Mar 31, 2025 | -6.69% |
| Dec 31, 2024 | 0.07% |
| Sep 30, 2024 | -37.84% |
| Jun 30, 2024 | -318.43% |
| Mar 31, 2024 | 681.22% |
| Dec 31, 2023 | 606.51% |
| Sep 30, 2023 | 51.87% |
| Jun 30, 2023 | 26.09% |
| Mar 31, 2023 | -42.87% |
| Dec 31, 2022 | -94.95% |
| Sep 30, 2022 | -37.95% |
| Jun 30, 2022 | 8.01% |
| Mar 31, 2022 | -29.03% |
| Dec 31, 2021 | 276.28% |
| Sep 30, 2021 | 1,295.42% |
| Jun 30, 2021 | -48.52% |
| Mar 31, 2021 | 107.43% |
| Dec 31, 2020 | 34.99% |
| Sep 30, 2020 | -111.85% |
| Jun 30, 2020 | 175.64% |
| Mar 31, 2020 | -804.36% |
| Dec 31, 2019 | 60.73% |
| Sep 30, 2019 | 339.65% |
| Jun 30, 2019 | 101.01% |
| Mar 31, 2019 | 348.69% |
| Dec 31, 2018 | 146.16% |
| Sep 30, 2018 | -19.08% |
| Jun 30, 2018 | 519.69% |
| Mar 31, 2018 | 78.01% |
| Dec 31, 2017 | -1,786.34% |
| Sep 30, 2017 | -2.23% |
| Jun 30, 2017 | -136.26% |
| Mar 31, 2017 | -877.99% |
| Dec 31, 2016 | -83.92% |
| Sep 30, 2016 | 193.17% |
| Jun 30, 2016 | 270.40% |
| Mar 31, 2016 | 230.98% |
| Dec 31, 2015 | 249.36% |
| Sep 30, 2015 | -166.76% |
| Jun 30, 2015 | 125.21% |
| Mar 31, 2015 | 45.93% |
| Dec 31, 2014 | 13.82% |
| Sep 30, 2014 | 369.06% |
| Jun 30, 2014 | -1,334.19% |
| Mar 31, 2014 | -116.71% |
| Dec 31, 2013 | -328.29% |
| Sep 30, 2013 | -1.51% |
| Jun 30, 2013 | -163.69% |
| Mar 31, 2013 | 65.51% |
| Dec 31, 2012 | 134.09% |
| Sep 30, 2012 | 59.10% |
| Jun 30, 2012 | 107.78% |
| Mar 31, 2012 | -71.34% |
| Dec 31, 2011 | -269.26% |
| Sep 30, 2011 | -67.43% |
| Jun 30, 2011 | -1,804.01% |
| Mar 31, 2011 | 25.80% |